Parenteral Drug Market
Parenteral Drug Market Study by Monoclonal Antibodies, Immunoglobulin, Cytokines, Peptide Hormones, Blood Factors, Vaccines, Small Molecule Antibiotics, and Chemotherapy Agents from 2024 to 2034
Analysis of Parenteral Drug Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Parenteral Drug Market Outlook (2024 to 2034)
Revenue in the global parenteral drug market, according to an updated Fact.MR report, is projected to reach US$ 595.63 billion in 2024. Worldwide sales of parenteral drugs have been forecasted to rise at a CAGR of 5.5% and climb to US$ 1,020.17 billion by 2034-end.
Several parenteral drug manufacturers are incorporating single-use strategies for proteins, antibodies, vaccines, cell therapy, and gene therapy. The United States FDA is recommending the use of automation in the production of more pharmaceuticals. Moreover, growing expenditure on pharmaceutical drugs is offering opportunities for market players to develop large-molecule drugs.
There is a rising demand for parenteral administration according to the drug proportion in the pipeline. This is owing to the rising consumption of biologic drugs globally. Several biologic drugs are presently available in injectable forms, thereby increasing the count of parenteral drugs in the pipeline, which is further generating lucrative opportunities for market players. Growing demand for monoclonal antibodies is due to the rising incidences of FDA approvals for products, which is further contributing to parenteral drug market trends.
- Worldwide demand for parenteral drugs for use in oncology is evaluated to increase at a CAGR of 8.3% and reach a market value of US$ 233.09 billion by the end of 2034.
- Global sales of large molecules-based parenteral drugs are projected to rise at 6.5% CAGR and reach US$ 696.42 billion by 2034-end.
- The market in Japan is analyzed to advance at a CAGR of 2.3% through 2034.
- Retail pharmacies are expected to capture 37.4% market share by the end of 2034.
- Sales of parenteral drugs in South Korea are projected to rise at 7% CAGR through 2034.
- South Asia & Pacific is forecasted to account for 22.9% of the global parenteral drug market share by 2034-end.
| Report Attribute | Detail |
|---|---|
| Parenteral Drug Market Size (2024E) | US$ 595.63 Billion |
| Forecasted Market Value (2034F) | US$ 1,020.17 Billion |
| Global Market Growth Rate (2024 to 2034) | 5.5% CAGR |
| China Market Growth Rate (2024 to 2034) | 9.4% CAGR |
| North America Market Share (2034F) | 33.6% |
| Market Share of Monoclonal Antibodies (2034F) | 22% |
| Key Companies Profiled | Merck & Co Inc.; Pfizer Inc.; Teva Pharmaceutical Industries Ltd.; Novartis AG; Sanofi S.A.; Sun Pharma; Cipla; AstraZeneca; Johnson & Johnson; Pfizer; AbbVie. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Why Will Parenteral Drugs Always Remain Key in Disease Treatment?
“Parenteral Drugs Facilitate Treatment with Quick Actions”
Increased demand for parenteral drugs is attributed to their suitability for patients in case medicines cannot be offered through the oral route. These drugs ensure a quick onset of action and are suitable for medicines that are inactivated by GIT (gastrointestinal tract). Moreover, the suitability of these drugs for patients in an unconscious state is also contributing to parenteral drug market growth.
Easy absorption of these medicines compared to oral medicines is contributing to a faster onset of actions. These medicines need not go through any digestive processes in the gastrointestinal tract, thereby having a different metabolism, subsequently resulting in stronger effects compared to oral medications.
How is Market Growth being Restrained to Some Extent?
“Lack of Automated and Cost-efficient Technology for Advanced Manufacturing Process”
Some of the leading market players are actively involved in new manufacturing techniques, which not only help in saving time but also money. However, a lack of automated as well as cost-effective automated technology for use in biologics is yet to be developed, which is somewhere limiting the expansion of the global parenteral drug market size.
“High Risk of Contamination with Parenteral Medications”
Orally administrated drugs in capsules and tablets form enter the intestine, which helps prevent microbial contaminants from entering into the bloodstream. Parenteral medications are injected, thereby delivered directly into the bloodstream and increasing the risks of contamination.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How are New Companies Penetrating This Business Space?
“Increasing Inclination to Single-use Equipment in Drug Production”
New market players are emphasizing the production and maintenance of high-quality products. They are using single-use technology to maintain the quality of produced biological parenteral drugs. In addition, they are also constantly putting efforts into incorporating QbD (Quality by Design) in their procedures, which is helping them ensure the consistent delivery of several high-quality products.
Country-wise Insights
North America is expected to account for 33.6% share of global market revenue by 2034, as revealed in the industry analysis published by Fact.MR, a market research and competitive intelligence provider. Some of the leading market players are investing significantly in advancements and modernization of facilities and innovative approaches for the development of parenteral drugs in the region. These will further aid healthcare providers in offering more effective facilities.
How is the Market for Parenteral Drugs Faring in the United States?
“Biopharma and Pharma Companies Enhancing Program Development Efforts”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 184.5 Billion |
| Growth Rate (2024 to 2034) | 4.9% CAGR |
| Projected Value (2034F) | US$ 296.97 Billion |
The United States is analyzed to hold 84.3% share of the North America market by the end of 2034. More biopharma and pharma companies are focusing on program development and manufacturing to match the surging demand for parenteral products. Intensifying regulatory frameworks are pushing the use of isolator technology to reduce potential risks associated with patients’ safety and expand the application scope of these drugs.
Why are Manufacturers of Parenteral Drugs Thriving in South Korea?
“High Spending on Healthcare and Related Facilities in the Country”
| Attribute | South Korea |
|---|---|
| Market Value (2024E) | US$ 25.18 Billion |
| Growth Rate (2024 to 2034) | 7% CAGR |
| Projected Value (2034F) | US$ 49.4 Billion |
South Korea is evaluated to account for 23.3% share of the East Asia market by 2034-end. There has been a noteworthy increase in the expenditure on ensuring access to more advanced pharmaceutical facilities. Market players need to scale up with the launch of new and more advanced parenteral drugs. In addition, increased expenditure by more individuals on healthcare facilities is also stimulating market players to offer more advanced facilities.
Which Factors are Paving the Way for Parenteral Drug Providers in India?
“Adoption of New Treatments and Offset of Patent Lifecycles”
| Attribute | India |
|---|---|
| Market Value (2024E) | US$ 30.73 Billion |
| Growth Rate (2024 to 2034) | 9.7% CAGR |
| Projected Value (2034F) | US$ 77.54 Billion |
India is forecasted to hold 60.5% share of South Asia & Pacific market revenue by the end of 2034. New treatment methods are incorporated by healthcare professionals along with offset of patent lifecycles. Fierce competition from generic biosimilars and generics is stimulating market players to increase their expenditure on the development of novel medicines, which is further widening opportunities for market players.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
Based on product type, worldwide demand for monoclonal antibodies is projected to increase at a 6.9% CAGR and reach a value of US$ 224.1 billion by 2034. These antibodies are used for restoring, enhancing, and modifying the immune attack, such as cancer cells.
Worldwide sales of parenteral drugs through retail pharmacies are projected to rise at a CAGR of 6.5% and reach US$ 381.79 billion by the end of 2034. These pharmacies ensure ease of access to drugs to the general public. These licensed stores are becoming more popular among healthcare providers for their authenticity or reliability.
Where is Use of Parenteral Drugs Extremely High?
“Parenteral Drugs Key Treatment Option for Cancer”
| Attribute | Oncology |
|---|---|
| Segment Value (2024E) | US$ 104.77 Billion |
| Growth Rate (2024 to 2034) | 8.3% CAGR |
| Projected Value (2034F) | US$ 233.09 Billion |
Oncology is evaluated to contribute 22.8% of the market share by the end of 2034. Oncology is a therapeutic area, which contributes to becoming a rich source of drug targets due to the incredible genotypic and phenotypic variations generally found among several types of cancer patients globally. These parenteral drugs help in preventing the spread of cancer to other human body parts, thereby slowing down cancer growth.
Which Parenteral Drugs Molecule Type is Gaining Prominence Globally?
“Biocompatible Nature of Parenteral Drugs Based on Large Molecules”
| Attribute | Large Molecules |
|---|---|
| Market Value (2024E) | US$ 370.75 Billion |
| Growth Rate (2024 to 2034) | 6.5% CAGR |
| Projected Value (2034F) | US$ 696.42 Billion |
Large molecule-based parenteral drugs are projected to occupy a share of 68.3% of the global market by 2034-end. An upward movement of large molecule drugs is attributed to their use in biological injectable preparations, which are further administered for treating several diseases, such as diabetes, blood disease, and cancer. The biocompatible nature of these large molecules is making them a popular option used in the pharmaceutical industry.
Competitive Landscape
Key players in the parenteral drug industry are consolidating their current manufacturing capabilities to capture a larger share of the global market. They are actively focusing on establishing new facilities and geographical expansions to target markets.
For instance :
- Merck & Co., Inc. is an American MNC headquartered in Rahway, New Jersey. The company is actively involved in the development of vaccines, medicines, parenteral drugs, animal health products, and biological therapies.
Fact.MR provides detailed information about the price points of leading manufacturers of parenteral drugs positioned across the world, sales growth, production capacity, and speculative technological expansion, in this updated market report.
Segmentation of Parenteral Drug Market Research
-
By Product Type :
- Monoclonal Antibodies
- Immunoglobulin
- Cytokines
- Insulin
- Blood Factors
- Peptide Hormones
- Vaccines
- Small Molecule Antibiotics
- Chemotherapy Agents
-
By Application :
- Oncology
- Infectious Diseases
- Diabetes
- Autoimmune Disorders
- Hormonal Disorders
- Musculoskeletal Disorders
- CNS Diseases
- Pain Management
- Cardiovascular Diseases
-
By Molecular Type :
- Small
- Large
-
By Route of Administration :
- Intravenous (IV)
- Intramuscular (IM
- Subcutaneous (SC)
-
By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
-
By Region :
- North America
- Latin America
- Western Europe
- Eastern Europe
- East Asia
- South Asia & Pacific
- MEA
Table of Content
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034 6.1. Application 6.2. Product Type 6.3. Molecular Type 6.4. Route of Administration 6.5. Distribution Channel 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Application 7.1. Oncology 7.2. Infectious Diseases 7.3. Diabetes 7.4. Autoimmune Disorders 7.5. Hormonal Disorders 7.6. Musculoskeletal Disorders 7.7. CNS Diseases 7.8. Pain Management 7.9. Cardiovascular Diseases 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Product Type 8.1. Monoclonal Antibodies 8.2. Immunoglobulin 8.3. Cytokines 8.4. Insulin 8.5. Blood Factors 8.6. Peptide Hormones 8.7. Vaccines 8.8. Small Molecule Antibiotics 8.9. Chemotherapy Agents 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Molecular Type 9.1. Small 9.2. Large 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Route of Administration 10.1. Intravenous (IV) 10.2. Intramuscular (IM 10.3. Subcutaneous (SC) 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Distribution Channel 11.1. Hospital Pharmacies 11.2. Retail Pharmacies 11.3. Drug Stores 11.4. Online Pharmacies 12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region 12.1. North America 12.2. Latin America 12.3. Western Europe 12.4. Eastern Europe 12.5. East Asia 12.6. South Asia & Pacific 12.7. Middle East & Africa 13. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 14. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 15. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 16. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 17. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 18. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 19. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 20. Sales Forecast 2024 to 2034 by Application, Product Type, Molecular Type, Route of Administration, Distribution Channel, and Region for 30 Countries 21. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 22. Company Profile 22.1. Merck & Co Inc. 22.2. Pfizer Inc. 22.3. Teva Pharmaceutical Industries Ltd. 22.4. Novartis AG 22.5. Sanofi S.A. 22.6. Sun Pharma 22.7. Cipla 22.8. AstraZeneca 22.9. Johnson & Johnson 22.10. Pfizer 22.11. AbbVie 23. Assumptions and Acronyms Used 24. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Application, 2019 to 2023
Table 02: Global Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 04: Global Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 05: Global Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 07: Global Market Value (US$ Mn) Analysis, by Molecular Type, 2019 to 2023
Table 08: Global Market Value (US$ Mn) Analysis, by Molecular Type, 2024 to 2034
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by Molecular Type, 2024 to 2034
Table 10: Global Market Value (US$ Mn) Analysis, by Route of Administration, 2019 to 2023
Table 11: Global Market Value (US$ Mn) Analysis, by Route of Administration, 2024 to 2034
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2024 to 2034
Table 13: Global Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 14: Global Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 15: Global Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 16: Global Market Value (US$ Mn) Analysis, by Region, 2019 to 2023
Table 17: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034
Table 18: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034
Table 19: North America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 20: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 22: North America Market Value (US$ Mn) Analysis, by Application, 2019 to 2023
Table 23: North America Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 25: North America Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 26: North America Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 27: North America Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 28: North America Market Value (US$ Mn) Analysis, by Molecular Type, 2019 to 2023
Table 29: North America Market Value (US$ Mn) Analysis, by Molecular Type, 2024 to 2034
Table 30: North America Market Value (US$ Mn) Opportunity Analysis, by Molecular Type, 2024 to 2034
Table 31: North America Market Value (US$ Mn) Analysis, by Route of Administration, 2019 to 2023
Table 32: North America Market Value (US$ Mn) Analysis, by Route of Administration, 2024 to 2034
Table 33: North America Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2024 to 2034
Table 34: North America Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 35: North America Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 36: North America Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 37: Latin America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 38: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 39: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 40: Latin America Market Value (US$ Mn) Analysis, by Application, 2019 to 2023
Table 41: Latin America Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 42: Latin America Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 43: Latin America Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 44: Latin America Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 45: Latin America Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 46: Latin America Market Value (US$ Mn) Analysis, by Molecular Type, 2019 to 2023
Table 47: Latin America Market Value (US$ Mn) Analysis, by Molecular Type, 2024 to 2034
Table 48: Latin America Market Value (US$ Mn) Opportunity Analysis, by Molecular Type, 2024 to 2034
Table 49: Latin America Market Value (US$ Mn) Analysis, by Route of Administration, 2019 to 2023
Table 50: Latin America Market Value (US$ Mn) Analysis, by Route of Administration, 2024 to 2034
Table 51: Latin America Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2024 to 2034
Table 52: Latin America Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 53: Latin America Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 54: Latin America Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 55: Western Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 56: Western Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 57: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 58: Western Europe Market Value (US$ Mn) Analysis, by Application, 2019 to 2023
Table 59: Western Europe Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 60: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 61: Western Europe Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 62: Western Europe Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 63: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 64: Western Europe Market Value (US$ Mn) Analysis, by Molecular Type, 2019 to 2023
Table 65: Western Europe Market Value (US$ Mn) Analysis, by Molecular Type, 2024 to 2034
Table 66: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Molecular Type, 2024 to 2034
Table 67: Western Europe Market Value (US$ Mn) Analysis, by Route of Administration, 2019 to 2023
Table 68: Western Europe Market Value (US$ Mn) Analysis, by Route of Administration, 2024 to 2034
Table 69: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2024 to 2034
Table 70: Western Europe Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 71: Western Europe Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 72: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 73: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 74: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 75: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 76: Eastern Europe Market Value (US$ Mn) Analysis, by Application, 2019 to 2023
Table 77: Eastern Europe Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 78: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 79: Eastern Europe Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 80: Eastern Europe Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 81: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 82: Eastern Europe Market Value (US$ Mn) Analysis, by Molecular Type, 2019 to 2023
Table 83: Eastern Europe Market Value (US$ Mn) Analysis, by Molecular Type, 2024 to 2034
Table 84: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Molecular Type, 2024 to 2034
Table 85: Eastern Europe Market Value (US$ Mn) Analysis, by Route of Administration, 2019 to 2023
Table 86: Eastern Europe Market Value (US$ Mn) Analysis, by Route of Administration, 2024 to 2034
Table 87: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2024 to 2034
Table 88: Eastern Europe Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 89: Eastern Europe Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 90: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 91: East Asia Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 92: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 93: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 94: East Asia Market Value (US$ Mn) Analysis, by Application, 2019 to 2023
Table 95: East Asia Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 96: East Asia Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 97: East Asia Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 98: East Asia Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 99: East Asia Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 100: East Asia Market Value (US$ Mn) Analysis, by Molecular Type, 2019 to 2023
Table 101: East Asia Market Value (US$ Mn) Analysis, by Molecular Type, 2024 to 2034
Table 102: East Asia Market Value (US$ Mn) Opportunity Analysis, by Molecular Type, 2024 to 2034
Table 103: East Asia Market Value (US$ Mn) Analysis, by Route of Administration, 2019 to 2023
Table 104: East Asia Market Value (US$ Mn) Analysis, by Route of Administration, 2024 to 2034
Table 105: East Asia Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2024 to 2034
Table 106: East Asia Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 107: East Asia Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 108: East Asia Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 109: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 110: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 111: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 112: South Asia & Pacific Market Value (US$ Mn) Analysis, by Application, 2019 to 2023
Table 113: South Asia & Pacific Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 114: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 115: South Asia & Pacific Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 116: South Asia & Pacific Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 117: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 118: South Asia & Pacific Market Value (US$ Mn) Analysis, by Molecular Type, 2019 to 2023
Table 119: South Asia & Pacific Market Value (US$ Mn) Analysis, by Molecular Type, 2024 to 2034
Table 120: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Molecular Type, 2024 to 2034
Table 121: South Asia & Pacific Market Value (US$ Mn) Analysis, by Route of Administration, 2019 to 2023
Table 122: South Asia & Pacific Market Value (US$ Mn) Analysis, by Route of Administration, 2024 to 2034
Table 123: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2024 to 2034
Table 124: South Asia & Pacific Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 125: South Asia & Pacific Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 126: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 127: MEA Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 128: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 129: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 130: MEA Market Value (US$ Mn) Analysis, by Application, 2019 to 2023
Table 131: MEA Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 132: MEA Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 133: MEA Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 134: MEA Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 135: MEA Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 136: MEA Market Value (US$ Mn) Analysis, by Molecular Type, 2019 to 2023
Table 137: MEA Market Value (US$ Mn) Analysis, by Molecular Type, 2024 to 2034
Table 138: MEA Market Value (US$ Mn) Opportunity Analysis, by Molecular Type, 2024 to 2034
Table 139: MEA Market Value (US$ Mn) Analysis, by Route of Administration, 2019 to 2023
Table 140: MEA Market Value (US$ Mn) Analysis, by Route of Administration, 2024 to 2034
Table 141: MEA Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2024 to 2034
Table 142: MEA Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 143: MEA Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 144: MEA Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034
Figure 05: Global Market Share and BPS Analysis by Application, 2024 & 2034
Figure 06: Global Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 07: Global Market Attractiveness Analysis by Application, 2024 to 2034
Figure 08: Global Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 09: Global Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 11: Global Market Share and BPS Analysis by Molecular Type, 2024 & 2034
Figure 12: Global Market Y-o-Y Growth Projections by Molecular Type, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by Molecular Type, 2024 to 2034
Figure 14: Global Market Share and BPS Analysis by Route of Administration, 2024 & 2034
Figure 15: Global Market Y-o-Y Growth Projections by Route of Administration, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Route of Administration, 2024 to 2034
Figure 17: Global Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 18: Global Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 19: Global Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 20: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 21: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034
Figure 22: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 23: North America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 24: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 25: North America Market Value Y-o-Y Growth and Forecast, 2034
Figure 26: North America Market Incremental $ Opportunity, 2024 to 2034
Figure 27: North America Market Share Analysis by Country, 2024 & 2034
Figure 28: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 29: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 30: North America Market Share and BPS Analysis by Application, 2024 & 2034
Figure 31: North America Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 32: North America Market Attractiveness Analysis by Application, 2024 to 2034
Figure 33: North America Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 34: North America Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 35: North America Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 36: North America Market Share and BPS Analysis by Molecular Type, 2024 & 2034
Figure 37: North America Market Y-o-Y Growth Projections by Molecular Type, 2024 to 2034
Figure 38: North America Market Attractiveness Analysis by Molecular Type, 2024 to 2034
Figure 39: North America Market Share and BPS Analysis by Route of Administration, 2024 & 2034
Figure 40: North America Market Y-o-Y Growth Projections by Route of Administration, 2024 to 2034
Figure 41: North America Market Attractiveness Analysis by Route of Administration, 2024 to 2034
Figure 42: North America Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 43: North America Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 44: North America Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 45: Latin America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 46: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 47: Latin America Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 48: Latin America Market Incremental $ Opportunity, 2024 to 2034
Figure 49: Latin America Market Share Analysis by Country, 2024 & 2034
Figure 50: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 51: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 52: Latin America Market Share and BPS Analysis by Application, 2024 & 2034
Figure 53: Latin America Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 54: Latin America Market Attractiveness Analysis by Application, 2024 to 2034
Figure 55: Latin America Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 56: Latin America Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 57: Latin America Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 58: Latin America Market Share and BPS Analysis by Molecular Type, 2024 & 2034
Figure 59: Latin America Market Y-o-Y Growth Projections by Molecular Type, 2024 to 2034
Figure 60: Latin America Market Attractiveness Analysis by Molecular Type, 2024 to 2034
Figure 61: Latin America Market Share and BPS Analysis by Route of Administration, 2024 & 2034
Figure 62: Latin America Market Y-o-Y Growth Projections by Route of Administration, 2024 to 2034
Figure 63: Latin America Market Attractiveness Analysis by Route of Administration, 2024 to 2034
Figure 64: Latin America Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 65: Latin America Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 66: Latin America Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 67: Western Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 68: Western Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 69: Western Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 70: Western Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 71: Western Europe Market Share Analysis by Country, 2024 & 2034
Figure 72: Western Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 73: Western Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 74: Western Europe Market Share and BPS Analysis by Application, 2024 & 2034
Figure 75: Western Europe Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 76: Western Europe Market Attractiveness Analysis by Application, 2024 to 2034
Figure 77: Western Europe Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 78: Western Europe Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 79: Western Europe Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 80: Western Europe Market Share and BPS Analysis by Molecular Type, 2024 & 2034
Figure 81: Western Europe Market Y-o-Y Growth Projections by Molecular Type, 2024 to 2034
Figure 82: Western Europe Market Attractiveness Analysis by Molecular Type, 2024 to 2034
Figure 83: Western Europe Market Share and BPS Analysis by Route of Administration, 2024 & 2034
Figure 84: Western Europe Market Y-o-Y Growth Projections by Route of Administration, 2024 to 2034
Figure 85: Western Europe Market Attractiveness Analysis by Route of Administration, 2024 to 2034
Figure 86: Western Europe Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 87: Western Europe Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 88: Western Europe Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 89: Eastern Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 90: Eastern Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 91: Eastern Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 92: Eastern Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 93: Eastern Europe Market Share Analysis by Country, 2024 & 2034
Figure 94: Eastern Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 95: Eastern Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 96: Eastern Europe Market Share and BPS Analysis by Application, 2024 & 2034
Figure 97: Eastern Europe Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 98: Eastern Europe Market Attractiveness Analysis by Application, 2024 to 2034
Figure 99: Eastern Europe Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 100: Eastern Europe Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 101: Eastern Europe Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 102: Eastern Europe Market Share and BPS Analysis by Molecular Type, 2024 & 2034
Figure 103: Eastern Europe Market Y-o-Y Growth Projections by Molecular Type, 2024 to 2034
Figure 104: Eastern Europe Market Attractiveness Analysis by Molecular Type, 2024 to 2034
Figure 105: Eastern Europe Market Share and BPS Analysis by Route of Administration, 2024 & 2034
Figure 106: Eastern Europe Market Y-o-Y Growth Projections by Route of Administration, 2024 to 2034
Figure 107: Eastern Europe Market Attractiveness Analysis by Route of Administration, 2024 to 2034
Figure 108: Eastern Europe Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 109: Eastern Europe Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 110: Eastern Europe Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 111: East Asia Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 112: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 113: East Asia Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 114: East Asia Market Incremental $ Opportunity, 2024 to 2034
Figure 115: East Asia Market Share Analysis by Country, 2024 & 2034
Figure 116: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 117: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 118: East Asia Market Share and BPS Analysis by Application, 2024 & 2034
Figure 119: East Asia Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 120: East Asia Market Attractiveness Analysis by Application, 2024 to 2034
Figure 121: East Asia Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 122: East Asia Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 123: East Asia Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 124: East Asia Market Share and BPS Analysis by Molecular Type, 2024 & 2034
Figure 125: East Asia Market Y-o-Y Growth Projections by Molecular Type, 2024 to 2034
Figure 126: East Asia Market Attractiveness Analysis by Molecular Type, 2024 to 2034
Figure 127: East Asia Market Share and BPS Analysis by Route of Administration, 2024 & 2034
Figure 128: East Asia Market Y-o-Y Growth Projections by Route of Administration, 2024 to 2034
Figure 129: East Asia Market Attractiveness Analysis by Route of Administration, 2024 to 2034
Figure 130: East Asia Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 131: East Asia Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 132: East Asia Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 133: South Asia & Pacific Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 134: South Asia & Pacific Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 135: South Asia & Pacific Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 136: South Asia & Pacific Market Incremental $ Opportunity, 2024 to 2034
Figure 137: South Asia & Pacific Market Share Analysis by Country, 2024 & 2034
Figure 138: South Asia & Pacific Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 139: South Asia & Pacific Market Attractiveness Analysis by Country, 2024 to 2034
Figure 140: South Asia & Pacific Market Share and BPS Analysis by Application, 2024 & 2034
Figure 141: South Asia & Pacific Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 142: South Asia & Pacific Market Attractiveness Analysis by Application, 2024 to 2034
Figure 143: South Asia & Pacific Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 144: South Asia & Pacific Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 145: South Asia & Pacific Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 146: South Asia & Pacific Market Share and BPS Analysis by Molecular Type, 2024 & 2034
Figure 147: South Asia & Pacific Market Y-o-Y Growth Projections by Molecular Type, 2024 to 2034
Figure 148: South Asia & Pacific Market Attractiveness Analysis by Molecular Type, 2024 to 2034
Figure 149: South Asia & Pacific Market Share and BPS Analysis by Route of Administration, 2024 & 2034
Figure 150: South Asia & Pacific Market Y-o-Y Growth Projections by Route of Administration, 2024 to 2034
Figure 151: South Asia & Pacific Market Attractiveness Analysis by Route of Administration, 2024 to 2034
Figure 152: South Asia & Pacific Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 153: South Asia & Pacific Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 154: South Asia & Pacific Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 155: MEA Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 156: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 157: MEA Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 158: MEA Market Incremental $ Opportunity, 2024 to 2034
Figure 159: MEA Market Share Analysis by Country, 2024 & 2034
Figure 160: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 161: MEA Market Attractiveness Analysis by Country, 2024 to 2034
Figure 162: MEA Market Share and BPS Analysis by Application, 2024 & 2034
Figure 163: MEA Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 164: MEA Market Attractiveness Analysis by Application, 2024 to 2034
Figure 165: MEA Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 166: MEA Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 167: MEA Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 168: MEA Market Share and BPS Analysis by Molecular Type, 2024 & 2034
Figure 169: MEA Market Y-o-Y Growth Projections by Molecular Type, 2024 to 2034
Figure 170: MEA Market Attractiveness Analysis by Molecular Type, 2024 to 2034
Figure 171: MEA Market Share and BPS Analysis by Route of Administration, 2024 & 2034
Figure 172: MEA Market Y-o-Y Growth Projections by Route of Administration, 2024 to 2034
Figure 173: MEA Market Attractiveness Analysis by Route of Administration, 2024 to 2034
Figure 174: MEA Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 175: MEA Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 176: MEA Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the market valuation of parenteral drugs in 2024?
The global parenteral drug market is projected to reach US$ 595.63 billion in 2024.
What are the sales projections for parenteral drugs by 2034?
Worldwide sales of parenteral drugs are forecasted to climb to US$ 1,020.17 billion by 2034.
At what rate is the global market approximated to expand?
The market for parenteral drugs is forecasted to advance at 5.5% CAGR from 2024 to 2034.
How much share of the global market is North America projected to hold?
North America is analyzed to hold a market share of 33.6% by 2034.
At what CAGR is the demand for parenteral drugs set to increase in South Korea?
The market for parenteral drugs in South Korea is projected to increase at a CAGR of 7% through 2034.
What is the market scenario for the oncology segment?
Revenue from parenteral drugs used in oncology is forecasted to rise at 8.3% CAGR and reach US$ 233.09 billion by 2034.
Who are some of the leading manufacturers of parenteral drugs?
Merck & Co Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, and Sanofi S.A. are some key market players.
What is parenteral in the pharmaceutical industry?
Parenteral preparations are defined as suspensions, solutions, and emulsions for infusion or injection, gels for implants, and injections used for administration of the human body.
Parenteral Drug Market